Author

Jung‐Hui Sun

Observed name: Jung-Hui Sun

Institution: Bristol-Myers Squibb (United States)

Observed institutions: DuPont (United States), Princeton University, Bristol-Myers Squibb (United States)

OpenAlex ID: A5111042377

Possible Role of Valvular Serotonin 5-HT2B Receptors in the Cardiopathy Associated with Fenfluramine

2000 · Lawrence W. Fitzgerald, Timothy C. Burn, et al. · Molecular Pharmacology · 436

MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products

1998 · John V. Duncia, Joseph B. Santella, et al. · Bioorganic & Medicinal Chemistry Letters · 398

Discovery of 1-(3‘-Aminobenzisoxazol-5‘-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2‘-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide Hydrochloride (Razaxaban), a Highly Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor

2004 · Mimi L. Quan, Patrick Y. S. Lam, et al. · Journal of Medicinal Chemistry · 191

Efficient Synthesis of 5-(Bromomethyl)- and 5-(Aminomethyl)-1-THP-Indazole

1997 · Jung-Hui Sun, Christopher A. Teleha, et al. · The Journal of Organic Chemistry · 129

Discovery and Preclinical Characterization of the Cyclopropylindolobenzazepine BMS-791325, A Potent Allosteric Inhibitor of the Hepatitis C Virus NS5B Polymerase

2014 · Robert G. Gentles, Min Ding, et al. · Journal of Medicinal Chemistry · 103

Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative Neoplasms

2015 · Honghe Wan, Gretchen M. Schroeder, et al. · ACS Medicinal Chemistry Letters · 40

Evaluation of a novel bis-naphthalimide anticancer agent, DMP 840, against human xenografts derived from adult, juvenile, and pediatric cancers

1994 · Peter J. Houghton, Pamela J. Cheshire, et al. · Cancer Chemotherapy and Pharmacology · 33

Potent, Orally Bioavailable, and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups

2019 · James R. Corte, Donald J. P. Pinto, et al. · Journal of Medicinal Chemistry · 30

Beyond U0126. Dianion chemistry leading to the rapid synthesis of a series of potent MEK inhibitors

2004 · John Wityak, Frank W. Hobbs, et al. · Bioorganic & Medicinal Chemistry Letters · 30

A New Synthesis of Aminomalononitrile Tosylate

1980 · Edward C. Taylor, Jung-Hui Sun · Synthesis · 24

The synthesis and antitumor evaluation of unsymmetrical bis-imides

1997 · Robert J. Cherney, Stephen G. Swartz, et al. · Bioorganic & Medicinal Chemistry Letters · 14

Discovery of 12 (BMS-986172) as a Highly Potent MGAT2 Inhibitor that Achieved Targeted Efficacious Exposures at a Low Human Dose for the Treatment of Metabolic Disorders

2023 · Wei Meng, Robert Brigance, et al. · Journal of Medicinal Chemistry · 12

Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1H-pyrazol-1-yl)methyl)phosphonate (BMS-820132)

2022 · Yan Shi, Ying Wang, et al. · Journal of Medicinal Chemistry · 12

Discovery of ((4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-f][1,2,4]triazine-6-carbonyl)(propyl)carbamoyloxy)methyl-2-(4-(phosphonooxy)phenyl)acetate (BMS-751324), a Clinical Prodrug of p38α MAP Kinase Inhibitor

2015 · Chunjian Liu, James Lin, et al. · Journal of Medicinal Chemistry · 9

Discovery of Indazoles as Potent, Orally Active Dual Neurokinin 1 Receptor Antagonists and Serotonin Transporter Inhibitors for the Treatment of Depression

2016 · Andrew P. Degnan, George O. Tora, et al. · ACS Chemical Neuroscience · 8

Development of the Large-Scale Synthesis of Tetrahydropyran Glycine, a Precursor to the HCV NS5A Inhibitor BMS-986097

2017 · Arvind Mathur, Bei Wang, et al. · The Journal of Organic Chemistry · 7

Synthesis Optimization, Scale-Up, and Catalyst Screening Efforts toward the MGAT2 Clinical Candidate, BMS-963272

2022 · James Kempson, Xiaoping Hou, et al. · Organic Process Research & Development · 6

The Reaction of 1,2-Diamines with a 2,3-Dioxopyrrolidines as an Approach to Pyrrolo[2,3-b]pyrazines

1977 · Stewart W. Schneller, Jung-Hui Sun · Heterocycles · 6

Evolution of the Synthetic Process to an Advanced GPR40 Agonist

2024 · Xiaoping Hou, Lucas W. Hernandez, et al. · Organic Process Research & Development · 3

An Efficient Synthesis of 2-(((9-Fluorenylmethoxycarbonyl)amino)methyl)benzoic Acid

1998 · Jung-Hui Sun, Wayne F. Daneker · Synthetic Communications · 3

Synthesis of N-Butyl Side Chain Hydroxylated Metabolites of Roxifiban, a Platelet Glycoprotein IIb/IIIa Receptor Antagonist

2004 · Jung-Hui Sun, George C. Emmett, et al. · Heterocycles · 1

Synthesis of Losoxantrone Metabolites Isolated from Human Urine

1999 · Jung-Hui Sun, Jiasheng Yan, et al. · Heterocycles · 1

ChemInform Abstract: Synthesis of Losoxantrone Metabolites Isolated from Human Urine.

2000 · Jung‐Hui Sun, Jiasheng Yan, et al. · ChemInform

ChemInform Abstract: An Efficient Synthesis of 2‐(((9‐Fluorenylmethoxycarbonyl)amino)methyl)benzoic Acid.

1999 · Jung‐Hui Sun, Wayne F. Daneker · ChemInform

Works count: 24

Citation count: 1,496

H-index: 12

I10-index: 13